GLP-1 receptor agonists are medications that increase the levels of this hormone in the body and restore its beneficial effects on blood sugars, sensations of fullness, and weight management
US weight-loss drugmakers slash prices in fight to win customers When Ruth Gonzalez decided to start taking the weight-loss medicine Zepbound last year, she first had to find a way to afford its roughly $350 (260) monthly cost
Today Lilly presented their results from a 26 week trial and showed their phase 2 drug at doses of 5mg and higher to be superior to their own Trulicity (dulaglutide) at a 1.5mg dose in terms of HbA1c reduction and weight loss
Diabetes Care 44(3):765773 Kim WJ, Lee SJ, Lee E, Lee EY, Han K (2022) Risk of incident dementia according to glycemic status and comorbidities of hyperglycemia: a nationwide population-based cohort study
External resources for researchers PubChem 5-Amino-1-methylquinolinium Open-access paper selective small-molecule NNMT inhibitors PubMed NNMT inhibition in preclinical metabolic research Related research products Disclaimer Used solely for in vitro experiments and cannot be: Used in clinical trials involving humans Administered to humans as part of an experiment or investigation Supplied to another party for human investigational use